Zonnebodo Pharmaceutical is engaged in manufacturing and marketing authorization holder of in-house developed prescription pharmaceuticals and quasi drugs. It manages long-selling products such as tablets for mitigating tinnitus and “Renovigo” for the prevention of tooth decay, and these items are sold at pharmacies and drug stores nationwide. Zonnebodo Pharmaceutical also possesses sophisticated manufacturing technologies and quality control capabilities in relation to a variety of drug forms, such as tablets, liquids and powders, and is building a robust business foundation in the pharmaceutical market. 
After joining Nissha Group in 2019, Zonnebodo Pharmaceutical launched a microneedle patch product and started marketing cosmetics in 2021.